Molecular alterations associated with bladder cancer initiation and progression

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Scandinavian Journal of Urology and Nephrology, Supplementum

• Publication date

  2008-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/03008880802291915PMID 18815930
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inactivation of p53 and Pten promotes invasive bladder cancer.

  2009cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Tenets of PTEN tumor suppression.

  2008cited by this paper
• Prognostic significance of p27Kip1 expression in bladder cancer

  2007cited by this paper
• Genomic and proteomic profiles reveal the association of gelsolin to TP53 status and bladder cancer progression.

  2007cited by this paper
• p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer.

  2007cited by this paper
• A Polymorphism in HDM2 (SNP309) Associates with Early Onset in Superficial Tumors, TP53 Mutations, and Poor Outcome in Invasive Bladder Cancer

  2007cited by this paper
• Mad2 overexpression promotes aneuploidy and tumorigenesis in mice.

  2007cited by this paper
• Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.

  2006cited by this paper
• Value of clusterin immunoreactivity as a predictive factor in muscle-invasive urothelial bladder carcinoma.

  2006cited by this paper
• Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis

  2006cited by this paper
• SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization.

  2006cited by this paper
• Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment.

  2006cited by this paper
• DBC1 re-expression alters the expression of multiple components of the plasminogen pathway

  2006cited by this paper
• Bladder cancer outcome and subtype classification by gene expression.

  2006cited by this paper
• Prognostic Significance of E2F3 Expression in Bladder Cancer

  2006cited by this paper
• Gene expression profiling of noninvasive primary urothelial tumours using microarrays

  2005cited by this paper
• Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and management

  2005cited by this paper
• Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways

  2005cited by this paper
• Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer

  2005cited by this paper
• High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumors.

  2005cited by this paper
• P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma.

  2005cited by this paper
• A propensity score approach to estimating the cost-effectiveness of medical therapies from observational data.

  2005cited by this paper
• Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth.

  2005influential reference
• High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancer.

  2005cited by this paper
• Profiling the Evolution of Human Metastatic Bladder Cancer

  2004cited by this paper
• Cancer genes and the pathways they control

  2004cited by this paper
• Amplification and overexpression of E2F3 in human bladder cancer

  2004cited by this paper
• Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control

  2004cited by this paper
• Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancer

  2004cited by this paper
• Reduced Expression of Metastasis Suppressor RhoGDI2 Is Associated with Decreased Survival for Patients with Bladder Cancer

  2004influential reference
• Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer

  2004cited by this paper
• Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses.

  2003cited by this paper
• Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome.

  2003influential reference
• Identifying distinct classes of bladder carcinoma using microarrays

  2003cited by this paper
• 8q24 Amplification in Transitional Cell Carcinoma of Bladder

  2003influential reference
• Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes.

  2002cited by this paper
• Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer

  2001cited by this paper
• Short Communication Frequent FGFR3 Mutations in Papillary Non-Invasive Bladder (pTa) Tumors

  2001cited by this paper
• Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2.

  2000cited by this paper
• The Pezcoller lecture: cancer cell cycles revisited.

  2000cited by this paper
• The multiple roles of PTEN in tumor suppression.

  2000cited by this paper
• High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer.

  2000influential reference
• Mutation of the 9q34 gene TSC1 in sporadic bladder cancer

  1999cited by this paper
• Somatic mutation of PTEN in bladder carcinoma

  1999cited by this paper
• Risk and Prognostic Factors- a Pathologist's Perspective

  1999cited by this paper
• Apoptosis and therapy

  1999cited by this paper
• Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors.

  1999cited by this paper
• Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence.

  1999cited by this paper
• Characterization of MAD2B and other mitotic spindle checkpoint genes.

  1999cited by this paper
• Bladder. Risk and prognostic factors--a pathologist's perspective.

  1999cited by this paper
• Evolving ideas about cyclins.

  1999cited by this paper
• Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.

  1999cited by this paper
• Intravesical bacille Calmette‐Guérin in the treatment of carcinoma in situ or high‐grade superficial bladder carcinoma after radiotherapy for bladder carcinoma

  1999cited by this paper
• Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy.

  1999cited by this paper
• Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization.

  1999cited by this paper
• PTCH gene mutations in invasive transitional cell carcinoma of the bladder

  1998cited by this paper
• The complexity of p53 modulation: emerging patterns from divergent signals.

  1998influential reference
• Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers

  1998cited by this paper
• Human Bub1: a putative spindle checkpoint kinase closely linked to cell proliferation.

  1998cited by this paper
• The checkpoint protein MAD2 and the mitotic regulator CDC20 form a ternary complex with the anaphase-promoting complex to control anaphase initiation.

  1998cited by this paper
• Mammalian p55CDC Mediates Association of the Spindle Checkpoint Protein Mad2 with the Cyclosome/Anaphase-promoting Complex, and is Involved in Regulating Anaphase Onset and Late Mitotic Events

  1998cited by this paper
• The Human Homologue of Bub3 Is Required for Kinetochore Localization of Bub1 and a Mad3/Bub1-related Protein Kinase

  1998cited by this paper
• Mutations of mitotic checkpoint genes in human cancers

  1998cited by this paper
• Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33.

  1998cited by this paper
• Mitotic Arrest: Mad2 Prevents Sleepy from Waking Up the APC

  1998influential reference
• Genetic instabilities in human cancers

  1998cited by this paper
• Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a

  1998cited by this paper
• Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes *

  1998cited by this paper
• Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins.

  1998cited by this paper
• p53, the Cellular Gatekeeper Review for Growth and Division

  1997cited by this paper
• CDC20 and CDH1: a family of substrate-specific activators of APC-dependent proteolysis.

  1997cited by this paper
• Alterations of tumor suppressor genes in bladder cancer.

  1997cited by this paper
• Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors.

  1997cited by this paper
• p53: puzzle and paradigm.

  1996cited by this paper
• Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex

  1996cited by this paper
• Identification of a Human Mitotic Checkpoint Gene: hsMAD2

  1996cited by this paper
• Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia.

  1995influential reference
• Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis

  1995cited by this paper
• G1 phase progression: cycling on cue.

  1994influential reference
• p53 mutations in human bladder cancer: Genotypic versus phenotypic patterns

  1994cited by this paper
• Mitosis in transition.

  1994influential reference
• Ordering S phase and M phase in the cell cycle.

  1994cited by this paper
• Accumulation of nuclear p53 and tumor progression in bladder cancer.

  1994cited by this paper
• Altered patterns of MDM2 and TP53 expression in human bladder cancer.

  1994cited by this paper
• Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.

  1993cited by this paper
• Genetic alterations in bladder cancer.

  1993cited by this paper
• Over‐expression of p53 nuclear oncoprotein in transitional‐cell bladder cancer and its prognostic value

  1993cited by this paper
• The Cell Cycle: An Introduction

  1993cited by this paper
• Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas.

  1992cited by this paper
• Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer.

  1992cited by this paper
• S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function.

  1991cited by this paper
• Cyclin is degraded by the ubiquitin pathway

  1991cited by this paper
• Feedback control of mitosis in budding yeast.

  1991cited by this paper
• Universal control mechanism regulating onset of M-phase

  1990cited by this paper
• Driving the cell cycle: M phase kinase, its partners, and substrates.

  1990cited by this paper
• Driving the cell cycle: M phase kinase, its partners, and substrates

  1990cited by this paper
• Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis

  1989cited by this paper
• Cancer statistics

  1989cited by this paper
• MPF from starfish oocytes at first meiotic metaphase is a heterodimer containing one molecule of cdc2 and one molecule of cyclin B.

  1989influential reference

• Differential Expression of One‐Carbon Pathway Enzyme ALDH1L1 Is Linked to Tumorigenicity of Low‐Grade Bladder Cancer Cells Through Metabolic Reprogramming

  2025cites this paper
• Molecular profiling of bladder cancer xenografts defines relevant molecular subtypes and provides a resource for biomarker discovery.

  2025cites this paper
• Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer

  2024cites this paper
• Comprehensive Genetic Profile of Chinese Muscle-Invasive Bladder Cancer Cohort.

  2024cites this paper
• Genç Yaşta Görülen Transizyonel Hücreli Mesane Karsinomunda Genetik Yatkınlık Var Mıdır?

  2023cites this paper
• Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ

  2023cites this paper
• Overexpression of MicroRNA-138 Affects the Proliferation and Invasion of Urothelial Carcinoma Cells by Suppressing SOX9 Expression

  2023cites this paper
• Association Between XRCC3 Thr241Met Gene Polymorphism and Susceptibility to Urothelial Carcinoma of the Bladder

  2022cites this paper
• Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy

  2022cites this paper
• Polygenic risk modeling of tumor stage and survival in bladder cancer

  2022cites this paper
• Comparative Analysis of Differentially Mutated Genes in Non-Muscle and Muscle-Invasive Bladder Cancer in the Chinese Population by Whole Exome Sequencing

  2022cites this paper
• Pathogenesis of Urothelial Carcinoma

  2022cites this paper
• The Origin and Evolution of Bladder Cancer Stem Cells

  2022cites this paper
• Non-Muscular Invasive Bladder Cancer: Re-envisioning Therapeutic Journey from Traditional to Regenerative Interventions

  2021cites this paper
• The Clinical Impact of Tumor Grade Heterogeneity in Non-muscle-invasive Urothelial Carcinoma of the Bladder

  2021cites this paper
• Cohesive cancer invasion of the biophysical barrier of smooth muscle

  2021cites this paper
• Frontiers in Bladder Cancer Genomic Research

  2021cites this paper
• Structure, regulatory factors and cancer-related physiological effects of ADAM9

  2020cites this paper
• A stemness-related seven-gene signature for predicting prognosis and treatment response in muscle invasive bladder cancer

  2020cites this paper
• Development of a 15-gene signature for predicting prognosis in advanced colorectal cancer

  2020cites this paper
• The therapeutic and prognostic implications of molecular biomarkers in urothelial carcinoma

  2020cites this paper
• Muscle-invasive Urothelial Cancer: Association of Mutational Status with Metastatic Pattern and Survival.

  2020cites this paper
• Beyond BCG: the approaching era of personalised bladder-sparing therapies for non-muscle-invasive urothelial cancers.

  2019cites this paper
• Identification of Significant Prognostic Tissue Markers Associated with Survival in Upper Urinary Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy: A Retrospective Immunohistochemical Analysis Using Tissue Microarray

  2019cites this paper
• A Festschrift in Honor of Edward M. Messing, MD, FACS

  2018cites this paper
• Pathophysiology of Bladder Cancer

  2018cites this paper
• The evolution of bladder cancer genomics: What have we learned and how can we use it?

  2018cites this paper
• Molecular Characterization of Bladder Cancer

  2018cites this paper
• Studying prostate cancer cell lines metabolome with FTIR spectroscopy

  2018cites this paper
• Immunohistochemical Investigation of HER/AKT/mTOR Pathway and Cellular Adhesion Molecules in Urothelial Carcinomas

  2017cites this paper
• Differential metallothionein isoform expression as biomarkers of cadmium exposure in human urothelium

  2017cites this paper
• Bladder cancer stem cells: clonal origin and therapeutic perspectives

  2017cites this paper
• Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients’ prognosis

  2017cites this paper
• Overexpression of UHRF1 gene correlates with the major clinicopathological parameters in urinary bladder cancer

  2017cites this paper
• Medical applications of the intrinsic mechanical properties of single cells.

  2016cites this paper
• Identification of 1p21-22 Amplification in Bladder Cancer and Expression of non-coding RNAs in Prostate Cancer

  2016influential citation
• Biological effects of eukaryotic recombinant plasmid pReceiver-M61-BAI-1 transfection on T24 cells and HUVECs

  2016cites this paper
• Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis

  2016cites this paper
• Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion

  2016cites this paper
• Recent Advances in the Diagnosis and Management of Bladder Cancer

  2015cites this paper
• The role of WNT signalling in urothelial cell carcinoma.

  2015cites this paper
• Genetic deletion and pharmacological inhibition of Akt1 isoform attenuates bladder cancer cell proliferation, motility and invasion.

  2015cites this paper
• Immunohistochemistry and Fluorescence In Situ Hybridization Can Inform the Differential Diagnosis of Low-Grade Noninvasive Urothelial Carcinoma with an Inverted Growth Pattern and Inverted Urothelial Papilloma

  2015cites this paper
• Bioinformatics analysis of the target gene of fibroblast growth factor receptor 3 in bladder cancer and associated molecular mechanisms.

  2015cites this paper
• Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.

  2015cites this paper
• Invasive low-grade papillary urothelial carcinoma: an immunohistochemical study of 26 cases.

  2015cites this paper
• Identification of New Hub Genes Associated with Bladder Carcinoma via Bioinformatics Analysis

  2015cites this paper
• Alterations of microsatellite loci GSN and D18S51 in urinary bladder cancer.

  2015cites this paper
• Roles of the small leucine-rich repeat proteoglycans OMD and PRELP in development and cancer

  2014cites this paper
• A new tumor suppressor role for the Notch pathway in bladder cancer

  2014cites this paper
• Bladder cancers arise from distinct urothelial sub-populations

  2014cites this paper
• MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9

  2014influential citation
• Lack of association between MTHFR Ala222Val and Glu429Ala polymorphisms and bladder cancer risk: A meta-analysis of case-control studies

  2014cites this paper
• Mapping of the chromosomal amplification 1p21-22 in bladder cancer

  2014cites this paper
• Fluid intake and risk of bladder cancer in the Nurses' Health Studies

  2014cites this paper
• Specific Activation of K-RasG12D Allele in the Bladder Urothelium Results in Lung Alveolar and Vascular Defects

  2014cites this paper
• Ki67 and TP53 expressions predict recurrence of non-muscle-invasive bladder cancer

  2014cites this paper
• Effect of PTEN Gene Mutations and Environmental Risk Factors on the Progression and Prognosis of Bladder Cancer

  2014cites this paper
• MRE11A and SKP2 genes are associated with the increased cytotoxicity induced by the synergistic effects of cisplatin and gemcitabine in bladder cancer cells

  2014cites this paper
• A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells.

  2013cites this paper
• DIGITAL QUANTITATIVE IMMUNOFLUORESCENT DETECTION OF p 53 PROTEIN IN URINARY BLADDER CANCER TISSUE

  2013cites this paper
• Relationship of TP53 and Ki67 expression in bladder cancer under WHO 2004 classification.

  2013cites this paper
• Mixed low- and high-grade papillary urothelial carcinoma: histopathogenetic and clinical significance

  2013cites this paper
• Cáncer de vejiga

  2013cites this paper
• Population-based study on prognostic factors for recurrence and progression in primary stage T1 bladder tumours

  2013cites this paper
• Prima-1 induces apoptosis in bladder cancer cell lines by activating p53

  2013cites this paper
• No evidence of correlation between p53 codon 72 polymorphism and risk of bladder cancer in Moroccan patients

  2013cites this paper
• Genetic Instability in Normal-Appearing and Tumor Urothelium Cells and the Role of the TP53 Gene in the Toxicogenomic Effects of Antineoplastic Drugs

  2013cites this paper
• Bioinformatics analysis of the gene expression profile in Bladder carcinoma

  2013cites this paper
• Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma

  2013influential citation
• The prevalence and prognostic significance of KRAS mutation in bladder cancer, chronic myeloid leukemia and colorectal cancer

  2013cites this paper
• Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer

  2013cites this paper
• Immunohistochemical characterization of urothelial carcinoma.

  2013cites this paper
• The Role of microRNAs in Bladder Urothelium Development and Tumorigenesis

  2013cites this paper
• Comparison of the clonality of urothelial carcinoma developing in the upper urinary tract and those developing in the bladder

  2013influential citation
• No relationship between the amount of DNA damage and the level of hMLH1 and RASSF1A gene expression in bladder cancer cells treated with cisplatin and gemcitabine.

  2013cites this paper
• P003 Effect of PTEN gene mutations and environmental risk factors on progression and prognosis of bladder cancer

  2013cites this paper
• Digital quantitative immunofluorescent detection of p53 protein in urinary bladder cancer tissue samples.

  2013cites this paper
• Transcriptional Modulation of the ERK1/2 MAPK and NF-κB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer.

  2012cites this paper
• Analysis of the Distribution and Temporal Trends of Grade and Stage in Urothelial Bladder Cancer in Northern New England from 1994 to 2004.

  2012cites this paper
• Toxicogenomic activity of gemcitabine in two TP53-mutated bladder cancer cell lines: special focus on cell cycle-related genes

  2012cites this paper
• STAGE T 1 URINARY BLADDER CARCINOMA : INVESTIGATION OF A POPULATION-BASED COHORT

  2012cites this paper
• Downregulation of integrin-linked kinase inhibits epithelial-to-mesenchymal transition and metastasis in bladder cancer cells.

  2012cites this paper
• A BAC-Based Transgenic Mouse Specifically Expresses an Inducible Cre in the Urothelium

  2012cites this paper
• The Use of Regenerative Medicine in the Management of Invasive Bladder Cancer

  2012cites this paper
• Time-dependent biological differences in molecular markers of high-grade urothelial cancer over 7 decades (ras proteins, pTEN, uPAR, PAI-1 and MMP-9)

  2012cites this paper
• Moving forward in bladder cancer detection and diagnosis: the role of epigenetic biomarkers

  2012cites this paper
• Cell-Cycle Control in Urothelial Carcinoma: Large-scale Tissue Array Analysis of Tumor Tissue from Maine and Vermont

  2012cites this paper
• Cytogenetic characterization of the murine bladder cancer model MB49 and the derived invasive line MB49-I.

  2012cites this paper
• Management of non-muscle-invasive (superficial) bladder cancer.

  2012cites this paper
• Stage T1 Urinary Bladder Carcinoma : Investigation of A Population-Based Cohort

  2012cites this paper
• Urothelial Tumors of the Bladder

  2012cites this paper
• Análise do efeito do Prima-1 na expressão dos genes envolvidos na morte celular programada em linhagens de câncer de bexiga

  2012cites this paper
• Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells

  2011cites this paper
• Molecular pathogenesis of non muscle-invasive bladder cancer: implications for novel targeted therapies.

  2011cites this paper
• The role of TP53 PRO47SER and ARG72PRO single nucleotide polymorphisms in the susceptibility to bladder cancer.

  2011cites this paper
• The mutational spectrum of HRAS, KRAS, NRAS and FGFR3 genes in bladder cancer

  2011cites this paper
• Up-regulation of BLT2 is critical for the survival of bladder cancer cells

  2011cites this paper
• Some molecular-genetic markers defining the pathogenesis of superficial and invasive bladder cancer

  2011cites this paper
• Knockdown of ribonuclease inhibitor expression with siRNA in non-invasive bladder cancer cell line BIU-87 promotes growth and metastasis potentials

  2011cites this paper